Exane Derivatives’s Healthpeak Properties DOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $337 | Sell |
13
-94
| -88% | -$2.85K | ﹤0.01% | 619 |
|
|
2022
Q1 | $3.67K | Hold |
107
| – | – | ﹤0.01% | 714 |
|
|
2021
Q4 | $3.86K | Sell |
107
-4,224
| -98% | -$146K | ﹤0.01% | 628 |
|
|
2021
Q3 | $145K | Sell |
4,331
-5,800
| -57% | -$205K | 0.03% | 468 |
|
|
2021
Q2 | $349K | Sell |
10,131
-1,964
| -16% | -$65.9K | 0.08% | 251 |
|
|
2021
Q1 | $384K | Sell |
12,095
-1,092
| -8% | -$33.2K | 0.11% | 183 |
|
|
2020
Q4 | $399K | Buy |
13,187
+3,729
| +39% | +$109K | 0.12% | 199 |
|
|
2020
Q3 | $257K | Buy |
9,458
+50
| +0.5% | +$1.37K | 0.07% | 190 |
|
|
2020
Q2 | $259K | Buy |
9,408
+3,829
| +69% | +$97.7K | 0.07% | 201 |
|
|
2020
Q1 | $133K | Sell |
5,579
-8,586
| -61% | -$280K | 0.04% | 245 |
|
|
2019
Q4 | $504K | Buy |
14,165
+3,984
| +39% | +$139K | 0.09% | 166 |
|
|
2019
Q3 | $363K | Hold |
10,181
| – | – | 0.07% | 187 |
|
|
2019
Q2 | $326K | Sell |
10,181
-435
| -4% | -$13.5K | 0.06% | 209 |
|
|
2019
Q1 | $332K | Sell |
10,616
-3,925
| -27% | -$120K | 0.07% | 182 |
|
|
2018
Q4 | $406K | Sell |
14,541
-8,800
| -38% | -$244K | 0.07% | 197 |
|
|
2018
Q3 | $606K | Sell |
23,341
-35,811
| -61% | -$941K | 0.11% | 149 |
|
|
2018
Q2 | $1.53M | Sell |
59,152
-18,062
| -23% | -$426K | 0.26% | 82 |
|
|
2018
Q1 | $1.81M | Buy |
77,214
+24,351
| +46% | +$566K | 0.36% | 76 |
|
|
2017
Q4 | $1.38M | Buy |
52,863
+2,628
| +5% | +$69.7K | 0.24% | 76 |
|
|
2017
Q3 | $1.4M | Buy |
50,235
+6,731
| +15% | +$202K | 0.26% | 72 |
|
|
2017
Q2 | $1.39M | Buy |
43,504
+2,627
| +6% | +$83.3K | 0.3% | 82 |
|
|
2017
Q1 | $1.28M | Buy |
40,877
+11,646
| +40% | +$358K | 0.29% | 82 |
|
|
2016
Q4 | $869K | Buy |
29,231
+1,443
| +5% | +$44K | 0.17% | 99 |
|
|
2016
Q3 | $960K | Buy |
27,788
+8,509
| +44% | +$298K | 0.14% | 93 |
|
|
2016
Q2 | $621K | Buy |
19,279
+16,393
| +568% | +$509K | 0.1% | 115 |
|
|
2016
Q1 | $85.6K | Sell |
2,886
-14,355
| -83% | -$431K | 0.01% | 257 |
|
|
2015
Q4 | $600K | Buy |
17,241
+4,697
| +37% | +$157K | 0.08% | 105 |
|
|
2015
Q3 | $426K | Sell |
12,544
-3,465
| -22% | -$120K | 0.05% | 135 |
|
|
2015
Q2 | $532K | Buy |
16,009
+6,051
| +61% | +$220K | 0.06% | 139 |
|
|
2015
Q1 | $392K | Buy |
9,958
+6,891
| +225% | +$277K | 0.04% | 160 |
|
|
2014
Q4 | $123K | Buy |
+3,067
| New | +$122K | 0.02% | 263 |
|
Other funds holding DOC
RC
Exane Derivatives's DOC Position: Q2 2022 in Review
Exane Derivatives reduced its Healthpeak Properties (DOC) stake by 88% in Q2 2022, selling an estimated $2.85K and leaving 13 shares worth $337. The position accounts for ﹤0.01% of the portfolio, ranked #619.
Exane Derivatives first reported a position in DOC in Q4 2014 and has held it in 31 quarters since. The position peaked at $1.81M in Q1 2018. 614 funds tracked by Wall St. Rank hold DOC as of Q2 2022.
- Exane Derivatives held 13 shares of Healthpeak Properties worth $337 as of Q2 2022.
- Exane Derivatives sold 94 Healthpeak Properties shares in Q2 2022, an estimated $2.85K.
- Healthpeak Properties made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #619 holding.
- Exane Derivatives first reported a position in Healthpeak Properties in Q4 2014 and has held it in 31 quarters since.
- Exane Derivatives's Healthpeak Properties position peaked at $1.81M in Q1 2018.
- 614 funds tracked by Wall St. Rank held Healthpeak Properties as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.